Oculis

Oculis is a Switzerland-based clinical-stage biopharmaceutical company that develops novel eye drops for the treatment of ophthalmic diseases.

Business Model:

Revenue: $10M

Employees: 11-50

Detailed Oculis Information

Geographic Data

Oculis headquarters map

Address: EPFL Innovation Park

City: Lausanne

State: vaud

Zip: C 1015

Country: CH

Financial Info

Stage:

series c

Raised Last:

$57M

Raised Total:

$94M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Oculis is a Switzerland-based clinical-stage biopharmaceutical company that develops novel eye drops for the treatment of ophthalmic diseases.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2012 Grant 1 $63.6k Technology Development Fund
Technology Development Fund
5/2021 Series C $0 Bay City Capital
Brunnur Ventures
BVCF
Earlybird Venture Capital
Hyfinity Investments
Nan Fung Life Sciences
Novartis Venture Fund
Pivotal bioVenture Partners
Silfurberg
Tekla Capital Management
VI Partners
Wille Finance
Bay City Capital
Brunnur Ventures
BVCF
Earlybird Venture Capital
Hyfinity Investments
Nan Fung Life Sciences
Novartis Venture Fund
Pivotal bioVenture Partners
Silfurberg
Tekla Capital Management
VI Partners
Wille Finance
8/2016 Series A 2 - Brunnur Ventures
Silfurberg
Brunnur Ventures
Silfurberg
1/2019 Series B 3 $15.7M Tekla Capital Management
Nan Fung Life Sciences
Brunnur Ventures
Tekla Capital Management
12/2016 Grant 1 $580k Technology Development Fund
Technology Development Fund
3/2015 Grant 1 $112.6k Technology Development Fund
Technology Development Fund
3/2011 Grant 1 $224.6k Technology Development Fund
Technology Development Fund
3/2008 Grant 1 $66.9k Technology Development Fund
Technology Development Fund
1/2018 Series B $20.5M Bay City Capital
Novartis Venture Fund
Pivotal bioVenture Partners
Brunnur Ventures
Silfurberg
10/2022 PIPE $80M Earlybird
Novartis Venture Fund
Pivotal bioVenture Partners
Tekla Capital Management LLC
VI Partners
1/2019 Series B $15.7M Tekla Capital Management
Nan Fung Life Sciences
2/2023 PIPE $15M
3/2013 Grant 1 $72.2k Technology Development Fund
Technology Development Fund
3/2023 Post-IPO Equity $0 Earlybird Venture Capital
Novartis Venture Fund
Pivotal bioVenture Partners
Tekla Capital Management
VI Partners
Earlybird Venture Capital
Novartis Venture Fund
Pivotal bioVenture Partners
Tekla Capital Management
VI Partners
Earlybird Venture Capital
Novartis Venture Fund
Pivotal bioVenture Partners
Tekla Capital Management
VI Partners
Earlybird Venture Capital
Novartis Venture Fund
Pivotal bioVenture Partners
Tekla Capital Management
VI Partners
1/2018 Series B 5 $20.5M Bay City Capital
Novartis Venture Fund
Pivotal bioVenture Partners
Silfurberg
Brunnur Ventures
Bay City Capital
Novartis Venture Fund
Pivotal bioVenture Partners
5/2021 Series C 12 $57M BVCF Management
Hyfinity Investments
VI Partners
Wille AG
Bay City Capital
Brunnur Ventures
EarlyBird
Pivotal bioVenture Partners
Nan Fung Life Sciences
Novartis Venture Funds
Bay City Capital
Brunnur Ventures
BVCF
Earlybird Venture Capital
Hyfinity Investments
Nan Fung Life Sciences
Novartis Venture Fund
Pivotal bioVenture Partners
Silfurberg
Tekla Capital Management
VI Partners
Wille Finance
8/2016 Series A 2 - Brunnur Ventures
Silfurberg
Brunnur Ventures
Silfurberg
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research